Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Bayer ( (DE:BAYN) ).
Bayer AG has announced the forthcoming disclosure of its financial reports for the year 2024 and the first half of 2025. The year-end financial report and the group report for 2024 will be published online on March 5, 2025, while the half-year report for 2025 will be available on August 6, 2025. These disclosures are crucial for stakeholders as they provide insights into the company’s financial health and strategic direction, potentially influencing market perceptions and investment decisions.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of healthcare and agriculture. It is known for producing pharmaceuticals, consumer health products, and crop science products, with a focus on innovation and sustainability in its operations.
YTD Price Performance: 1.67%
Average Trading Volume: 751,980
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €19.26B
For an in-depth examination of BAYN stock, go to TipRanks’ Stock Analysis page.